Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty. [electronic resource]
Producer: 20110825Description: S22-6 p. digitalISSN:- 1936-2692
- Anticoagulants -- economics
- Arthroplasty, Replacement, Hip -- adverse effects
- Arthroplasty, Replacement, Knee -- adverse effects
- Cost-Benefit Analysis
- Enoxaparin -- economics
- Factor Xa Inhibitors
- Humans
- Morpholines -- economics
- Rivaroxaban
- Thiophenes -- economics
- United States
- Venous Thromboembolism -- economics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.